前列腺癌放疗后髋部并发症的长期风险:剂量-效应研究
研究纳入1997至2002年接受根治性外照射放疗的349例前列腺癌患者及1661例匹配对照,中位随访16.0年。髋骨折风险未见增加。
要点
- 前列腺癌外照射放疗后髋骨关节炎风险升高,10年累积发生率8.1%对4.9%。
- 股骨头接受EQD2≥40 Gy的体积与髋骨关节炎风险显著相关。
- 中位随访16.0年未发现髋骨折风险增加。
核心结论
- 常规外照射放疗后长期随访未增加髋骨折风险,但髋骨关节炎风险升高。
- 髋骨关节炎与股骨头接受EQD2≥40 Gy的体积存在剂量-效应关系。
研究设计与样本
- 纳入1997至2002年接受根治性外照射放疗的349例前列腺癌患者,最终346例可分析。
- 从瑞典前列腺癌数据库选取1661例年龄匹配对照。
- 推导股骨头、耻骨和骶骨的物理及分次校正剂量-体积描述符。
- 采用单变量和多变量Cox比例风险回归分析事件时间。
主要发现
- 股骨头中位平均物理剂量35.5 Gy,对应EQD2为28.7 Gy。
- 中位随访16.0年,发生12例髋骨折。
- 诊断髋骨关节炎36例,其中29例导致置换手术。
- 10年髋骨关节炎累积发生率放疗组8.1%,对照组4.9%。
关键数值与推荐
- 髋骨关节炎与股骨头接受EQD2≥40 Gy的体积显著相关。
临床怎么用
- 前列腺癌放疗计划中应关注股骨头EQD2≥40 Gy的体积,以降低远期髋骨关节炎风险。
- 长期随访中需关注髋骨关节炎及置换手术风险,髋骨折风险未见增加。
局限性
- 研究基于1997至2002年接受常规放疗的患者,结论外推至现代技术需谨慎。
- 髋骨关节炎诊断可能受监测偏倚影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of the present study was to analyze the long-term incidence of hip complications after external beam radiation therapy compared with age-matched controls from the general population. We also investigated whether there were any dose-response associations. METHODS AND MATERIALS: A total of 349 patients with prostate cancer treated to curative dose with external beam radiation therapy between 1997 and 2002 were included in the study. Physical and fractionation-corrected dose-volume descriptors were derived for the femoral heads, pubic bone, and sacrum. Information on skeletal events was collected for the patients and 1661 matched controls through the Prostate Cancer database Sweden. Uni- and multivariable Cox proportional hazard regressions were used to analyze the time to event. RESULTS: Data from 346 patients were available for analysis. The median mean physical dose and corresponding equivalent 2-Gy/fraction dose (EQD2) to the femoral heads were 35.5 Gy and 28.7 Gy, respectively. The median follow-up time was 16.0 years. During the follow up, 12 hip fractures occurred. Hip osteoarthritis was diagnosed in 36 cases, with 29 cases leading to replacement surgery. No increased risk of hip fractures was found. Hip osteoarthritis was the only event for which a statistically significant difference was found between the irradiated cohort and the controls (cause-specific hazard ratio: 1.56; 95% confidence interval, 1.07-2.26; P = .02). The cumulative incidence of osteoarthritis at 10 years was 8.1% and 4.9% in the irradiated cohort and the controls, respectively. A significant relationship between osteoarthritis and the volume of the femoral head receiving ≥40 Gy (ie, EQD2) was found. CONCLUSIONS: In this study of 346 patients treated with conventional radiation therapy, we found no increased risk of hip fracture but an increased risk of clinically relevant osteoarthritis at long-term follow up. Our results indicate a dose-response relationship between osteoarthritis and the volume of the femoral head receiving an EQD2 dose of ≥40 Gy.
引用
- Rasmusson E, Nilsson P, Kjellén E, et al. Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study. Adv Radiat Oncol. 2020. PMID: 33665484. doi:10.1016/j.adro.2020.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。